3652 results for «223»
3652 results
TAVI procedural complications - Part 3: vascular complications, coronary issues and more
19 May 2026 – From EuroPCR 2026
This session addresses critical procedural complications during TAVI, emphasizing vascular issues, coronary complications, and complex bailout scenarios. Through challenging case examples, it offers insights into the management and anticipation of such complications to optimize patient outcomes.
STEMI presenting with cardiogenic shock
19 May 2026 – From EuroPCR 2026
This session covers acute management of STEMI presenting with cardiogenic shock, illustrating advanced interventional strategies and support devices such as ECMO, IABP, and Impella. It reviews complex clinical scenarios including acute left main occlusion and multivessel disease, offering critical insights into emergent care and decision-making.
Stent failure evaluation with intracoronary imaging
19 May 2026 – From EuroPCR 2026
This session provides an in-depth evaluation of stent failure using intracoronary imaging modalities such as IVUS and OCT. It presents diverse cases illustrating late drug-eluting stent failure, in-stent restenosis, neoatherosclerosis, and complications following rotational atherectomy, underscoring imaging's role in diagnosis and guiding reintervention.
Leaflet modification techniques during TAVI
19 May 2026 – From EuroPCR 2026
This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Thrombectomy in pulmonary embolism
19 May 2026 – From EuroPCR 2026
This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...
Place of DCB in clinical practice
19 May 2026 – From EuroPCR 2026
This session explores the clinical applications of drug-coated balloons (DCB) across diverse challenging scenarios. It covers management of severely calcified nodules in acute coronary syndrome, healing of intentional dissections in chronic total occlusions using paclitaxel DCB, strategic integration of contemporary technology in complex lesion treatment, and...
Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
